As Bayer management predicted, it seems as though the German conglomerate’s for-sale animal health business has indeed attracted high interest. China’s Fosun International, parent of Fosun Pharma, is considering teaming up with private equity firms or other investors for a joint offer for Bayer’s animal health business, Bloomberg reported, citing people familiar with the matter.
On Thursday, Bicycle Therapeutics announced the appointments of Lisa Mahnke as senior vice president and head of clinical and Terrence West as vice president and head of program management to help expand and advance its clinical pipeline.